MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about BLUE

Recent news which mentions BLUE

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Bluebird (BLUE) Stock Soars 25% Following 2 FDA Recommendations
Tickers BLUE
Tags Market News BLUE NASDAQ:BLUE
From InvestorPlace
Mid-Morning Market Update: Markets Open Lower; Dow Drops 600 Points
Tickers APLD APPH BLUE DAWN
Tags Market News BLUE Eurozone
From Benzinga
FDA Advisory Committee Backs Bluebird Bio's Blood Disorder Gene Therapy
Tickers BLUE
Tags FDA Trading Ideas Benzinga
From Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Tickers ABVC ACXP ALRN BLUE
Tags BZI/TFM ZSAN ACXP
From Benzinga
Bluebird Bio stock rises 62%, FDA committee supports treatments
Tickers BLUE
Tags BLUE
From MarketWatch
An FDA Approval Could Send This Stock Soaring by August
Tickers BLUE
Tags Market News BLUE Recent Press Releases
From Motley Fool
Bluebird Bio Secures FDA Advisory Committee's Endorsement For Neurodegenerative Disease Drug
Tickers BLUE
Tags FDA Benzinga Biotech
From Benzinga
FDA Sounds Positive On Bluebird's One Gene Therapy But Doubts Another
Tickers BLUE
Tags FDA Trading Ideas Benzinga
From Benzinga
6 Biotech Stocks to Buy Now Ahead of These June Catalysts
Tickers ACAD AXSM BLUE BMY
Tags GSK AXSM SRRA
From InvestorPlace
Stocks That Hit 52-Week Lows On Thursday
Tickers ACOR ADN AERI AFIB
Tags PBLA CVNA CHRS
From Benzinga
TC BioPharm Reports Racing Toward What Could Be A Major Cancer Immunotherapy Breakthrough
Tickers BLUE TCBP
Tags Benzinga TC Biopharm Partner Content
From Benzinga
Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates
Tickers ACAD ACER AMLX BLUE
Tags HZNP BNTX PFE
From Benzinga
7 Cheap Biotech Stocks to Buy Now
Tickers AMGN BCRX BLUE BNGO
Tags AMGN BNGO IBRX
From InvestorPlace
2 High-Risk, High-Reward Stocks for Contrarian Investors
Tickers BLUE PRVB
Tags BLUE Market News Recent Press Releases
From Motley Fool
These 5-Stock Samplers Have Gotten Whacked. And That's OK
Tickers AAPL ABNB AMGN AMZN
Tags AMGN AXON SE
From Motley Fool
Why This Analyst Has 'Little Conviction' On CRISPR's Upcoming Trial Data
Tickers ALLO BLUE CRSP VRTX
Tags Price Target Briefs VRTX
From Benzinga
Analyst Ratings for bluebird bio
Tickers BLUE
Tags Analyst Ratings Market News BLUE
From Benzinga
92 Biggest Movers From Friday
Tickers ACOR ACRX AERI AMLX
Tags Trading Ideas AREN STGW
From Benzinga
55 Stocks Moving In Friday's Mid-Day Session
Tickers AOSL ATGE AVDX BBIG
Tags Markets USX AOSL
From Benzinga
Where Will Bluebird Bio Be in 1 Year?
Tickers BLUE
Tags Recent Press Releases BLUE Market News
From Motley Fool
Is Bluebird Bio a Buy?
Tickers BLUE
Tags Recent Press Releases BLUE Market News
From Motley Fool
Layoffs at Bluebird Bio Highlight the Current Struggles of Biotech Picks
Tickers BIIB BLUE GILD IBB
Tags XBI GILD PFE
From InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022
Tickers ABMD AMP APTV ARRY
Tags Analyst Ratings GTES PJT
From Benzinga
Expert Ratings For bluebird bio
Tickers BLUE
Tags BZI/AAR Benzinga Analyst Ratings
From Benzinga
10 Biggest Price Target Changes For Wednesday
Tickers AMP BLUE C CANO
Tags HYZN JAZZ CANO
From Benzinga
Bluebird Bio Joins Layoff Band Wagon As Gene Therapy Biotech Cuts Staff To Reduce Costs
Tickers BLUE
Tags BLUE Market News Health Care
From Benzinga
FDA Recommends At Least 15 years Of Follow-Up For Genome Editing Product Trials
Tickers BLUE NTLA
Tags Gene Editing Health Care FDA
From Benzinga
Why Bluebird Bio Stock Is Sinking This Week
Tickers BLUE
Tags Recent Press Releases BLUE Market News
From Motley Fool
bluebird bio's Return On Capital Employed Insights
Tickers BLUE
Tags BLUE Market News BZI/ROCE
From Benzinga
76 Biggest Movers From Yesterday
Tickers ADTH ANTE APPH ARMP
Tags PETV GOL GBR
From Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story